{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:37:12Z","timestamp":1775806632393,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1038\/ncprheum0510","type":"journal-article","created":{"date-parts":[[2007,5,30]],"date-time":"2007-05-30T16:10:11Z","timestamp":1180541411000},"page":"328-335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?"],"prefix":"10.1038","volume":"3","author":[{"given":"Petros","family":"Efthimiou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolos","family":"Kontzias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla M","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeta S","family":"Ogden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncprheum0510_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/ard.30.2.121","volume":"30","author":"EG Bywaters","year":"1971","unstructured":"Bywaters EG (1971) Still's disease in the adult. Ann Rheum Dis 30: 121\u2013133","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0510_CR2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/ard.2005.042143","volume":"65","author":"P Efthimiou","year":"2006","unstructured":"Efthimiou P et al. (2006) Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 65: 564\u2013572","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0510_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/pmj.78.916.97","volume":"78","author":"GS Stoica","year":"2002","unstructured":"Stoica GS et al. (2002) Adult Still's disease and respiratory failure in a 74 year old woman. Postgrad Med J 78: 97\u201398","journal-title":"Postgrad Med J"},{"key":"BFncprheum0510_CR4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.berh.2004.05.004","volume":"18","author":"J Kadar","year":"2004","unstructured":"Kadar J and Petrovicz E (2004) Adult-onset Still's disease. Best Pract Res Clin Rheumatol 18: 663\u2013676","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"BFncprheum0510_CR5","first-page":"1055","volume":"61","author":"JM Wouters","year":"1986","unstructured":"Wouters JM and van de Putte LB (1986) Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases. Q J Med 61: 1055\u20131065","journal-title":"Q J Med"},{"key":"BFncprheum0510_CR6","first-page":"1058","volume":"17","author":"A Ohta","year":"1990","unstructured":"Ohta A et al. (1990) Adult Still's disease: a multicenter survey of Japanese patients. J Rheumatol 17: 1058\u20131063","journal-title":"J Rheumatol"},{"key":"BFncprheum0510_CR7","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1086\/517644","volume":"26","author":"G Longo","year":"1998","unstructured":"Longo G et al. (1998) Still's disease, severe thrombocytopenia, and acute hepatitis associated with acute parvovirus B19 infection. Clin Infect Dis 26: 994\u2013995","journal-title":"Clin Infect Dis"},{"key":"BFncprheum0510_CR8","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/0140-6736(93)91184-N","volume":"341","author":"J Pouchot","year":"1993","unstructured":"Pouchot J et al. (1993) Adult Still's disease associated with acute human parvovirus B19 infection. Lancet 341: 1280\u20131281","journal-title":"Lancet"},{"key":"BFncprheum0510_CR9","doi-asserted-by":"publisher","first-page":"E105","DOI":"10.1086\/319342","volume":"32","author":"C Perez","year":"2001","unstructured":"Perez C and Artola V (2001) Adult Still's disease associated with Mycoplasma pneumoniae infection. Clin Infect Dis 32: E105\u2013E106","journal-title":"Clin Infect Dis"},{"key":"BFncprheum0510_CR10","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1136\/ard.47.9.764","volume":"47","author":"JM Wouters","year":"1988","unstructured":"Wouters JM et al. (1988) Adult onset Still's disease and viral infections. Ann Rheum Dis 47: 764\u2013767","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0510_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/art.1780290316","volume":"29","author":"JM Wouters","year":"1986","unstructured":"Wouters JM et al. (1986) Adult-onset Still's disease. Disease course and HLA associations. Arthritis Rheum 29: 415\u2013418","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0510_CR12","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/art.1780241203","volume":"24","author":"R Terkeltaub","year":"1981","unstructured":"Terkeltaub R et al. (1981) HLA-Bw35 and prognosis in adult Still's disease. Arthritis Rheum 24: 1469\u20131472","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0510_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/art.1780280207","volume":"28","author":"ML Miller","year":"1985","unstructured":"Miller ML et al. (1985) HLA gene frequencies in children and adults with systemic onset juvenile rheumatoid arthritis. Arthritis Rheum 28: 146\u2013150","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0510_CR14","first-page":"489","volume":"21","author":"CI Joung","year":"2003","unstructured":"Joung CI et al. (2003) Association between HLA-DRB1 and clinical features of adult onset Still's disease in Korea. Clin Exp Rheumatol 21: 489\u2013492","journal-title":"Clin Exp Rheumatol"},{"key":"BFncprheum0510_CR15","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1093\/rheumatology\/40.12.1398","volume":"40","author":"T Fujii","year":"2001","unstructured":"Fujii T et al. (2001) Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease. Rheumatology (Oxford) 40: 1398\u20131404","journal-title":"Rheumatology (Oxford)"},{"key":"BFncprheum0510_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0950-3579(05)80283-3","volume":"5","author":"LB van de Putte","year":"1991","unstructured":"van de Putte LB and Wouters JM (1991) Adult-onset Still's disease. Baillieres Clin Rheumatol 5: 263\u2013275","journal-title":"Baillieres Clin Rheumatol"},{"key":"BFncprheum0510_CR17","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1136\/jcp.2004.018010","volume":"57","author":"YK Jeon","year":"2004","unstructured":"Jeon YK et al. (2004) Spectrum of lymph node pathology in adult onset Still's disease; analysis of 12 patients with one follow up biopsy. J Clin Pathol 57: 1052\u20131056","journal-title":"J Clin Pathol"},{"key":"BFncprheum0510_CR18","first-page":"124","volume":"23","author":"T Hoshino","year":"1996","unstructured":"Hoshino T et al. (1996) TCR gamma delta + T cells in peripheral blood of patients with adult Still's disease. J Rheumatol 23: 124\u2013129","journal-title":"J Rheumatol"},{"key":"BFncprheum0510_CR19","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1136\/ard.2003.013680","volume":"63","author":"DY Chen","year":"2004","unstructured":"Chen DY et al. (2004) Predominance of TH1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease. Ann Rheum Dis 63: 1300\u20131306","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0510_CR20","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S0952-7915(96)80122-1","volume":"8","author":"LL Carter","year":"1996","unstructured":"Carter LL and Dutton RW (1996) Type 1 and type 2: a fundamental dichotomy for all T-cell subsets. Curr Opin Immunol 8: 336\u2013342","journal-title":"Curr Opin Immunol"},{"key":"BFncprheum0510_CR21","first-page":"2189","volume":"31","author":"DY Chen","year":"2004","unstructured":"Chen DY et al. (2004) Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. J Rheumatol 31: 2189\u20132198","journal-title":"J Rheumatol"},{"key":"BFncprheum0510_CR22","first-page":"396","volume":"25","author":"T Hoshino","year":"1998","unstructured":"Hoshino T et al. (1998) Elevated serum interleukin 6, interferon-\u03b3, and tumor necrosis factor-\u03b1 levels in patients with adult Still's disease. J Rheumatol 25: 396\u2013398","journal-title":"J Rheumatol"},{"key":"BFncprheum0510_CR23","first-page":"1071","volume":"29","author":"MA Muzaffer","year":"2002","unstructured":"Muzaffer MA et al. (2002) Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis. J Rheumatol 29: 1071\u20131078","journal-title":"J Rheumatol"},{"key":"BFncprheum0510_CR24","doi-asserted-by":"publisher","first-page":"R1281","DOI":"10.1186\/ar1826","volume":"7","author":"P Woo","year":"2005","unstructured":"Woo P et al. (2005) Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. Arthritis Res Ther 7: R1281\u2013R1288","journal-title":"Arthritis Res Ther"},{"key":"BFncprheum0510_CR25","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/1529-0131(200103)44:3<550::AID-ANR103>3.0.CO;2-5","volume":"44","author":"M Kawashima","year":"2001","unstructured":"Kawashima M et al. (2001) Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum 44: 550\u2013560","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0510_CR26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1189\/jlb.0905516","volume":"79","author":"WG Tharp","year":"2006","unstructured":"Tharp WG et al. (2006) Neutrophil chemorepulsion in defined interleukin-8 gradients in vitro and in vivo. J Leukoc Biol 79: 539\u2013554","journal-title":"J Leukoc Biol"},{"key":"BFncprheum0510_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0091-6749(99)70518-X","volume":"103","author":"CA Dinarello","year":"1999","unstructured":"Dinarello CA (1999) IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 103: 11\u201324","journal-title":"J Allergy Clin Immunol"},{"key":"BFncprheum0510_CR28","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1172\/JCI1379","volume":"101","author":"AJ Puren","year":"1998","unstructured":"Puren AJ et al. (1998) Interleukin-18 (IFN\u03b3-inducing factor) induces IL-8 and IL-1beta via TNF\u03b1 production from non-CD14+ human blood mononuclear cells. J Clin Invest 101: 711\u2013721","journal-title":"J Clin Invest"},{"key":"BFncprheum0510_CR29","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1002\/1529-0131(200107)44:7<1716::AID-ART298>3.0.CO;2-I","volume":"44","author":"Y Kawaguchi","year":"2001","unstructured":"Kawaguchi Y et al. (2001) Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease. Arthritis Rheum 44: 1716\u20131717","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0510_CR30","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1136\/ard.2003.016428","volume":"63","author":"T Rooney","year":"2004","unstructured":"Rooney T et al. (2004) Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis. Ann Rheum Dis 63: 1393\u20131398","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0510_CR31","first-page":"673","volume":"6","author":"JM Esdaile","year":"1979","unstructured":"Esdaile JM et al. (1979) Hepatic abnormalities in adult onset Still's disease. J Rheumatol 6: 673\u2013679","journal-title":"J Rheumatol"},{"key":"BFncprheum0510_CR32","first-page":"1093","volume":"30","author":"A Ogata","year":"2003","unstructured":"Ogata A et al. (2003) Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still's disease. J Rheumatol 30: 1093\u20131096","journal-title":"J Rheumatol"},{"key":"BFncprheum0510_CR33","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/sj.gene.6363922","volume":"3","author":"T Sugiura","year":"2002","unstructured":"Sugiura T et al. (2002) Association between adult-onset Still's disease and interleukin-18 gene polymorphisms. Genes Immun 3: 394\u2013399","journal-title":"Genes Immun"},{"key":"BFncprheum0510_CR34","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/ar1930","volume":"8","author":"T Sugiura","year":"2006","unstructured":"Sugiura T et al. (2006) A promoter haplotype of the interleukin-18 gene is associated with juvenile idiopathic arthritis in the Japanese population. Arthritis Res Ther 8: R60","journal-title":"Arthritis Res Ther"},{"key":"BFncprheum0510_CR35","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/rheumatology\/38.5.477","volume":"38","author":"K Matsui","year":"1999","unstructured":"Matsui K et al. (1999) High serum level of macrophage-colony stimulating factor (M-CSF) in adult-onset Still's disease. Rheumatology (Oxford) 38: 477\u2013478","journal-title":"Rheumatology (Oxford)"},{"key":"BFncprheum0510_CR36","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1002\/art.20178","volume":"50","author":"R Donn","year":"2004","unstructured":"Donn R et al. (2004) A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum 50: 1604\u20131610","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0510_CR37","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1073\/pnas.012511599","volume":"99","author":"RA Mitchell","year":"2002","unstructured":"Mitchell RA et al. (2002) Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci USA 99: 345\u2013350","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncprheum0510_CR38","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/art.21164","volume":"53","author":"DY Chen","year":"2005","unstructured":"Chen DY et al. (2005) Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease. Arthritis Rheum 53: 320\u2013327","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0510_CR39","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1084\/jem.20050473","volume":"201","author":"V Pascual","year":"2005","unstructured":"Pascual V et al. (2005) Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 201: 1479\u20131486","journal-title":"J Exp Med"},{"key":"BFncprheum0510_CR40","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1084\/jem.20050640","volume":"201","author":"CA Dinarello","year":"2005","unstructured":"Dinarello CA (2005) Blocking IL-1 in systemic inflammation. J Exp Med 201: 1355\u20131359","journal-title":"J Exp Med"},{"key":"BFncprheum0510_CR41","first-page":"758","volume":"62","author":"C Masson","year":"1995","unstructured":"Masson C et al. (1995) Adult Still's disease. Part II. Management, outcome, and prognostic factors. Rev Rhum Engl Ed 62: 758\u2013765","journal-title":"Rev Rhum Engl Ed"},{"key":"BFncprheum0510_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0049-0172(87)90015-1","volume":"17","author":"AJ Reginato","year":"1987","unstructured":"Reginato AJ et al. (1987) Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum 17: 39\u201357","journal-title":"Semin Arthritis Rheum"},{"key":"BFncprheum0510_CR43","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/art.1780300209","volume":"30","author":"JJ Cush","year":"1987","unstructured":"Cush JJ et al. (1987) Adult-onset Still's disease. Clinical course and outcome. Arthritis Rheum 30: 186\u2013194","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0510_CR44","first-page":"373","volume":"26","author":"B Fautrel","year":"1999","unstructured":"Fautrel B et al. (1999) Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease. J Rheumatol 26: 373\u2013378","journal-title":"J Rheumatol"},{"key":"BFncprheum0510_CR45","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/0248-8663(96)80703-X","volume":"16","author":"S Permal","year":"1995","unstructured":"Permal S et al. (1995) Treatment of Still disease in adults with intravenous immunoglobulins. Rev Med Intern 16: 250\u2013254","journal-title":"Rev Med Intern"},{"key":"BFncprheum0510_CR46","first-page":"295","volume":"16","author":"S Vignes","year":"1998","unstructured":"Vignes S et al. (1998) Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol 16: 295\u2013298","journal-title":"Clin Exp Rheumatol"},{"key":"BFncprheum0510_CR47","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/ard.2004.024026","volume":"64","author":"B Fautrel","year":"2005","unstructured":"Fautrel B et al. (2005) Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis 64: 262\u2013266","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0510_CR48","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1055\/s-2004-826865","volume":"129","author":"C Dechant","year":"2004","unstructured":"Dechant C et al. (2004) Long-term outcome of TNF blockade in adult-onset Still's disease [German]. Dtsch Med Wochenschr 129: 1308\u20131312","journal-title":"Dtsch Med Wochenschr"},{"key":"BFncprheum0510_CR49","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/art.10231","volume":"46","author":"ME Husni","year":"2002","unstructured":"Husni ME et al. (2002) Etanercept in the treatment of adult patients with Still's disease. Arthritis Rheum 46: 1171\u20131176","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0510_CR50","first-page":"733","volume":"23","author":"M Benucci","year":"2005","unstructured":"Benucci M et al. (2005) Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report [letter]. Clin Exp Rheumatol 23: 733","journal-title":"Clin Exp Rheumatol"},{"key":"BFncprheum0510_CR51","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/art.21061","volume":"52","author":"AA Fitzgerald","year":"2005","unstructured":"Fitzgerald AA et al. (2005) Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis Rheum 52: 1794\u20131803","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0510_CR52","first-page":"4101","volume":"52","author":"C Chu","year":"2005","unstructured":"Chu C et al. (2005) Interleukin-1 blockade is an effective treatment of adult onset Still's disease. Arthritis Rheum 52: 4101","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0510_CR53","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","volume":"70","author":"J Pouchot","year":"1991","unstructured":"Pouchot J et al. (1991) Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 70: 118\u2013136","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl 3","key":"BFncprheum0510_CR54","doi-asserted-by":"crossref","first-page":"iii55","DOI":"10.1136\/ard.60.90003.iii55","volume":"60","author":"HG Kraetsch","year":"2001","unstructured":"Kraetsch HG et al. (2001) Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences. Ann Rheum Dis 60 (Suppl 3): iii55\u2013iii57","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0510_CR55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10067-003-0775-5","volume":"23","author":"A Kokkinos","year":"2004","unstructured":"Kokkinos A et al. (2004) Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients. Clin Rheumatol 23: 45\u201349","journal-title":"Clin Rheumatol"},{"key":"BFncprheum0510_CR56","first-page":"293","volume":"63","author":"B Haraoui","year":"2004","unstructured":"Haraoui B et al. (2004) Anakinra in the treatment of adult onset Still's disease. Ann Rheum Dis 63: 293\u2013294","journal-title":"Ann Rheum Dis"}],"container-title":["Nature Clinical Practice Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0510","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0510.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0510.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T19:58:37Z","timestamp":1737057517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["BFncprheum0510"],"URL":"https:\/\/doi.org\/10.1038\/ncprheum0510","relation":{},"ISSN":["1745-8382","1745-8390"],"issn-type":[{"value":"1745-8382","type":"print"},{"value":"1745-8390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"3 January 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}